Nathalie Van Den Haute
Nathalie is a managing director at Oaklins KBC Securities in Belgium. She has 15 years of corporate finance and investment banking experience, specializing in mergers & acquisitions (both buy- and sell-side), equity capital markets (initial and secondary public offerings and rights issues) and strategic and financial advisory (valuations, finance structurings, market screenings and independent expert reports). Although Nathalie has transaction experience in a broad range of industries, one of her focus areas has been the life sciences sector. She serves as a board member of Flanders.bio, an independent member-driven life sciences cluster organization in Flanders, for Oaklins KBC Securities. Notable clients she has advised include Sequana, Biocartis, Mithra, Tigenix, argenx, Ablynx, Galapagos and Oxurion.
Nathalie joined the corporate finance team in 2005 after obtaining a master’s in commercial engineering (magna cum laude) from Solvay Management School (VUB) and a master’s in financial management (magna cum laude) from Vlerick Business School.